Literature DB >> 7719411

Detection of immunoreactive antigen, with a monoclonal antibody to measles virus, in tissue from a patient with Crohn's disease.

H Miyamoto1, T Tanaka, N Kitamoto, Y Fukuda, T Shimoyama.   

Abstract

Using immunofluorescence (IF), we investigated reactive antigens present in Crohn's disease patients with monoclonal antibodies derived from cells infected with measles virus, but not with the subacute sclerosing panencephalitis virus. During immunoblotting, one monoclonal antibody (mAb 86) reacted with a polypeptide with a molecular weight of 36,000 dalton (M; matrix protein) in measles virus-infected cells. This monoclonal antibody displayed a positive reaction only with tissues from patients with Crohn's disease by the IF test. It did not react with samples from patients with other chronic inflammatory bowel diseases, such as ulcerative colitis. Other monoclonal antibodies to the measles virus protein, and monoclonal antibodies to Herpes simplex virus type 1 did not react with the same tissue samples. The role of measles virus infection and/or a viral antigen (possibly the M protein) as a causative agent in Crohn's disease poses a challenging avenue for further research.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719411     DOI: 10.1007/bf01211371

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  41 in total

1.  Studies on the viral etiology of regional enteritis and ulcerative colitis: a negative report.

Authors:  S S SCHNEIERSON; J H GARLOCK; B SHORE; W D STUART; M STEINGLASS; B ARONSON
Journal:  Am J Dig Dis       Date:  1962-09

2.  The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies.

Authors:  H Sheshberadaran; E Norrby; K C McCullough; W C Carpenter; C Orvell
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

3.  Sarcoidosis, another disease associated with serologic evidence for herpes-like virus infection.

Authors:  Y Hirshaut; P Glade; B D Vieira; E Ainbender; B Dvorak; L E Siltzbach
Journal:  N Engl J Med       Date:  1970-09-03       Impact factor: 91.245

Review 4.  Measles and SSPE viruses: similarities and differences.

Authors:  S L Wechsler; H C Meissner
Journal:  Prog Med Virol       Date:  1982

Review 5.  Recent developments in nonspecific inflammatory bowel disease (second of two parts).

Authors:  J B Kirsner; R G Shorter
Journal:  N Engl J Med       Date:  1982-04-08       Impact factor: 91.245

6.  Herpes-like virus and granulomatous colitis.

Authors:  H Grtsky; P R Glade; Y Hirshaut; D Sachar; H D Janowitz
Journal:  Lancet       Date:  1970-12-12       Impact factor: 79.321

7.  Measles virus matrix protein detected by immune fluorescence with monoclonal antibodies in the brain of patients with subacute sclerosing panencephalitis.

Authors:  E Norrby; K Kristensson; W J Brzosko; J G Kapsenberg
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

8.  An antibody against revertant forms of cell-wall deficient bacterial variant in sera from patients with Crohn's disease.

Authors:  A Shafii; S Sopher; M Lev; K M Das
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

9.  Detection of viral antigens in formalin-fixed specimens by enzyme treatment.

Authors:  T Kurata; R Hondo; S Sato; A Oda; Y Aoyama; J B McCormick
Journal:  Ann N Y Acad Sci       Date:  1983       Impact factor: 5.691

10.  Cross-reactivity between cowpox and vaccinia viruses with monoclonal antibodies. Brief report.

Authors:  N Kitamoto; E Goto; S Tanimoto; T Tanaka; H Miyamoto; N Wakamiya; K Ikuta; S Ueda; S Kato
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more
  11 in total

1.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

Review 2.  Detection of persistent measles virus infection in Crohn's disease: current status of experimental work.

Authors:  S Ghosh; E Armitage; D Wilson; P D Minor; M A Afzal
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  No evidence of persisting measles virus in the intestinal tissues of patients with inflammatory bowel disease.

Authors:  Yasmin D'Souza; Serge Dionne; Ernest G Seidman; Alain Bitton; Brian J Ward
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

Review 4.  MMR: where are we now?

Authors:  David Elliman; Helen Bedford
Journal:  Arch Dis Child       Date:  2007-07-11       Impact factor: 3.791

5.  Measles virus and Crohn's disease: view of a medical virologist.

Authors:  V ter Meulen
Journal:  Gut       Date:  1998-12       Impact factor: 23.059

6.  Immunohistochemical analysis of the distribution of measles related antigen in the intestinal mucosa in inflammatory bowel disease.

Authors:  M Iizuka; M Chiba; M Yukawa; T Nakagomi; T Fukushima; S Watanabe; O Nakagomi
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

7.  Food induced stimulation of the antisecretory factor can improve symptoms in human inflammatory bowel disease: a study of a concept.

Authors:  S Björck; I Bosaeus; E Ek; E Jennische; I Lönnroth; E Johansson; S Lange
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

8.  Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy.

Authors:  P Daszak; M Purcell; J Lewin; A P Dhillon; R E Pounder; A J Wakefield
Journal:  J Clin Pathol       Date:  1997-04       Impact factor: 3.411

9.  Detection of measles virus mRNA from autopsied human tissues.

Authors:  Y Katayama; K Kohso; A Nishimura; Y Tatsuno; M Homma; H Hotta
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 10.  Measles vaccination and inflammatory bowel disease: controversy laid to rest?

Authors:  R L Davis; K Bohlke
Journal:  Drug Saf       Date:  2001       Impact factor: 5.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.